Pharmaceutical company Mylan received FDA approval of its Abbreviated New Drug Application for Etomidate Injection, a generic anesthesia drug, according to iStockAnalyst.com.
Etomidate Injection is the generic version of Hospira’s Amidate Injection, which is an intravenous general anesthesia.
The newly-approved drug has begun shipping in the United States, and sales for the last 12 months of Etomidate Injection, ending in March, were $6.58M.
More Articles on Anesthesia:
Dr. McCallum R. Hoyt Appointed President of Society for Obstetric Anesthesia and Perinatology
Anesthesiologist Named Chief Medical Officer of Rosellini Scientific
Finding the Right “Fit”: Career Tips for Anesthesia Graduates
